Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study in healthy volunteers evaluating oral bioavailability of GSK962040 with an IV microtracer, study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Drugs mentioned

• GSK962040

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gastroparesis | Phase 1 | Status: COMPLETED